Regular paper
Pretreatment with Endothelin-1 Mimics Ischemic Preconditioning Against Infarction in Isolated Rabbit Heart

https://doi.org/10.1006/jmcc.1996.0054Get rights and content

Abstract

We have proposed that ischemic preconditioning in rabbit hearts is initiated by adenosine receptor stimulation resulting in activation of protein kinase C. If this theory is correct then any agonist which can activate PKC should also put the heart into a preconditioned state. This study sought to determine whether endothelin-1 (ET-1), which is known to activate protein kinase C, can also mimic ischemic preconditioning. Isolated rabbit hearts experienced 30 min of regional ischemia followed by 120 min of reperfusion. Infarct size was measured with triphenyltetrazolium chloride. In control hearts infarction was 30.3±2.5% of the risk zone. Preconditioning with 5 min global ischemia and 10 min reperfusion reduced infarct size to 5.6±0.7% (P<0.01). Perfusion with either 10 pmET-1 at constant coronary artery flow for 5 minin lieuof ischemia or 50 pmET-1 with 10 nmnicardipine to block the former's coronary constrictive effect was quite protective and equipotent with preconditioning. Infarction averaged 7.2±0.8% and 5.8±1.7% of the risk zone, respectively. This protection could be blocked by PD 156 707 (10μm), a highly specific endothelin receptor antagonist. Chelerythrine (5μm), a PKC inhibitor, also aborted protection (22.0±1.7% infarction). However, 8-(p-sulfophenyl)theophylline (100μm), an adenosine receptor blocker, given during ET-1 administration did not block ET-1's protective effect indicating that adenosine was not involved in the effect. PD 156 707 failed to block the protection from ischemic preconditioning (12.6±2.3% infarction) revealing that endothelin is not an important physiological mediator of ischemic preconditioning. We conclude that ET-1 can mimic ischemic preconditioning in isolated rabbit hearts as would be predicted since its receptors are PKC-coupled, but that endogenous endothelin contributes little to ischemic preconditioning.

References (0)

Cited by (90)

  • Cardioprotective signalling: Past, present and future

    2018, European Journal of Pharmacology
    Citation Excerpt :

    Extracellular Ca2+, halogenated gases, nitric oxide (NO), reactive oxygen and nitrogen species as well as hydrogen sulphide (H2S) have been shown to induce cardioprotection (Johnson et al., 1991; Miyawaki et al., 1996; Konorev et al., 1999; Sodha et al., 2009; Guerrero-Orriach et al., 2017). In addition, adenosine, acetylcholine, angiotensin, bradykinin, catecholamines, phenylephrine, endothelin, opioids, adrenomedullin, natriuretic peptides, nicotinamide, urocortin, leptin, epoxyeicosanotrienoic acids, insulin-growth factor 1, fibroblast growth factors 1 and 2, and tumor necrosis factor α (TNFα), among others, have all been shown to confer cardioprotection when exogenously administrated (Eddy et al., 1992; Toombs et al., 1992; Yao and Gross, 1993; Liu et al., 1995; Padua et al., 1995; Meng et al., 1996; Wang et al., 1996; Okosi et al., 1998; Cohen et al., 2001; D'Souza et al., 2003; Nithipatikom et al., 2006; Santini et al., 2007; Nishida et al., 2008; Sukhodub et al., 2010). The number of procedures/compounds that could induce cardioprotection is fascinating and every day there are published reports about yet another cardioprotective agent and/or procedure.

  • Conditioning the whole heart-not just the cardiomyocyte

    2012, Journal of Molecular and Cellular Cardiology
    Citation Excerpt :

    Endothelin-1 (ET1) receptor agonists were recognised early on as a pharmacological trigger of preconditioning [29], with evidence of ET1 receptors on the myocardial cell surface [29]. However, while ET1 administered as an exogenous bolus to trigger conditioning is effective [29], the endothelial release of ET1 during transient ischaemia/reperfusion is probably insufficient to trigger ischaemic preconditioning on its own, and ET1 receptor antagonists insufficient to attenuate ischaemic preconditioning [30]. Endothelial-derived kinins however have the potential play a far more important role in the preconditioning trigger stimulus [31].

  • Cardioprotective signaling to mitochondria

    2009, Journal of Molecular and Cellular Cardiology
    Citation Excerpt :

    Ischemic preconditioning (IPC) and ischemic postconditioning are receptor-mediated processes that are triggered by GPCR agonists released by the ischemic heart, primarily bradykinin, opioid peptides, and adenosine [19]. Other GPCR ligands, including acetylcholine, catecholemines, endothelin, and angiotensin II, are also cardioprotective [20–24], but they were found not to be physiological triggers of IPC [14]. A composite diagram of the GPCR signaling pathways is given in Fig. 1.

View all citing articles on Scopus

Please address all correspondence to: Michael V. Cohen, Department of Physiology, MSB 3050, University of South Alabama, College of Medicine, Mobile, AL 36688, U.S.A.

View full text